Author

B. Cigolini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

A. Ballestrero· 2 shared D. Bedognetti· 2 shared D. Chaussabel· 2 shared D. Rinchai· 2 shared G. Gentilcore· 2 shared G. Zoppoli· 2 shared J.-C. Grivel· 2 shared A. A. Hssain· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Ballestrero

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune-checkpoint inhibitors

F. Ravera, M. Dameri, I. Lombardo, M. Stabile, N. Fallani, C. Scarsi, B. Cigolini, G. Gentilcore, A. Domnich, L. Zullo, E. Cella, G. Francia, E. Montanari, A. Orsi, A. Bellodi, , G. Zoppoli

This study examines how rituximab and immune-checkpoint inhibitors affect immune responses to a COVID-19 booster vaccine, finding rituximab impairs interferon response and ICI maintains normal immune profiles.

bioRxiv · Mar 5, 2024Immunology

High temporal resolution systems profiling reveals distinct patterns of interferon response after Covid-19 mRNA vaccination and SARS-CoV2 infection

D. Rinchai, S. Deola, G. Zoppoli, B. S. A. Kabeer, S. A. Taleb, I. Pavlovski, S. Maacha, G. Gentilcore, M. Toufiq, L. Matthew, L. Liu, F. R. Vempalli, G. Mubarak, S. Lorenz, I. Sivieri, , D. Chaussabel

This study uses high-temporal-resolution transcriptome profiling to compare interferon responses after mRNA vaccination and SARS-CoV-2 infection, identifying distinct signatures linked to immune outcomes.

bioRxiv · Dec 12, 2021 · PreprintImmunology